Table 5. Unconditional logistic regression adjusted for age and multivariable analyses and estimated partial AR at death for dementia.
Neuropathological Findings | Age Adjusted Analysis | Multivariable Analysis | AR | ||||
OR | 95% CI | p-Value | OR | 95% CI | Percent | 95% CI | |
Age at death (y) | |||||||
<80 | 1.0 | — | — | 1.0 | — | — | — |
80–89 | 3.2 | 1.8–5.5 | — | 2.5 | 1.1–5.8 | 8 | 0–16 |
≥90 | 5.2 | 2.9–9.4 | <0.001 | 3.4 | 1.4–8.3 | 10 | 3–16 |
Time since last interview (y) | — | — | — | Not included | — | Not included | — |
<1 | 1.0 | — | — | — | — | — | — |
>1 | 1.2 | 0.8–1.7 | 0.5 | — | — | — | — |
Brain weight for sex (g) | |||||||
Low | 5.7 | 3.2–10 | <0.001 | 4.1 | 1.9–9.2 | 12 | 5–19 |
Average | 2.0 | 1.2–34 | — | 2.1 | 1.0–4.2 | 5 | 0–11 |
High | 1.0 | — | — | 1.0 | — | — | — |
Neuritic plaques in neocortex | |||||||
None | 1.0 | — | — | 1.0 | — | — | — |
Mild | 1.2 | 0.7–2.2 | — | 1.0 | — | — | — |
Moderate | 2.9 | 1.7–5.0 | — | 1.0 | — | — | — |
Severe | 18.5 | 7.3–47 | <0.001 | 9.7 | 2.1–43 | 8 | 3–14 |
Diffuse plaques in neocortex | — | — | — | Not included | — | Not included | — |
None | 1.0 | — | — | — | — | — | |
Mild | 1.4 | 0.7–2.5 | — | — | — | — | — |
Moderate | 1.6 | 0.9–2.9 | — | — | — | — | — |
Severe | 4.2 | 2.3–7.9 | <0.001 | — | — | — | — |
NFT in neocortex | |||||||
None | 1.0 | — | — | 1.0 | — | — | — |
Mild | 1.3 | 0.8–2.1 | — | 1.0 | 0.5–1.8 | — | — |
Moderate | 8.9 | 4.0–20 | — | 7.1 | 2.3–22 | 11 | 5–19 |
Severe | ∞ | — | <0.001 | — | — | — | — |
Neuritic plaques in hippocampus | — | — | — | Not included | — | Not included | — |
None | 1.0 | — | — | — | — | — | — |
Mild | 1.9 | 1.1–3.3 | — | — | — | — | — |
Moderate | 3.5 | 2.1–5.9 | — | — | — | — | — |
Severe | 8.5 | 3.2–22 | <0.001 | — | — | — | — |
Diffuse plaques in hippocampus | — | — | — | Not included | — | Not included | — |
None | 1.0 | — | — | — | — | — | — |
Mild | 1.5 | 0.9–2.5 | — | — | — | — | — |
Moderate | 2.0 | 1.1–3.5 | — | — | — | — | — |
Severe | 2.2 | 0.7–7.2 | 0.06 | — | — | — | — |
Tangles in hippocampus | — | — | — | Not included | — | Not included | — |
None | 1.0 | — | — | — | — | — | — |
Mild | 1.3 | 0.6–2.8 | — | — | — | — | — |
Moderate | 2.7 | 1.2–5.9 | — | — | — | — | — |
Severe | 8.4 | 3.7–19 | <0.001 | — | — | — | — |
Neuritic plaques in the entorhinal cortex | — | — | — | Not included | — | Not included | — |
None | 1.0 | — | — | — | — | — | — |
Mild | 1.9 | 1.1–3.1 | — | — | — | — | — |
Moderate | 3.7 | 2.1–6.5 | — | — | — | — | — |
Severe | 11.1 | 4.0–30 | <0.001 | — | — | — | — |
Diffuse plaques in the entorhinal cortex | — | — | — | Not included | — | Not included | — |
None | 1.0 | — | — | — | — | — | — |
Mild | 2.2 | 1.3–3.8 | — | — | — | — | — |
Moderate | 2.6 | 1.5–4.4 | — | — | — | — | — |
Severe | 5.5 | 2.5–12 | <0.001 | — | — | — | — |
Tangles in entorhinal cortex | — | — | — | Not included | — | Not included | — |
None | 1.0 | — | — | — | — | — | — |
Mild | 1.7 | 0.6–4.5 | — | — | — | — | — |
Moderate | 3.4 | 1.4–8.6 | — | — | — | — | — |
Severe | 12.7 | 4.8–34 | <0.001 | — | — | — | — |
CAA | |||||||
None | 1.0 | — | — | 1.0 | 1.0 | — | — |
Mild | 1.9 | 1.1–3.3 | — | 1.8 | 0.8–3.8 | 2 | 0–6 |
Moderate | 4.0 | 2.2–7.4 | — | 2.9 | 1.2–6.8 | 5 | 1–10 |
Severe | ∞ | — | <0.001 | 2.9 | 1.2–6.8 | 5 | 1–10 |
Moderate/severe CAA | — | — | — | Not included | — | Not included | — |
No | 1.0 | — | — | — | — | — | — |
Yes | 4.3 | 2.4–7.6 | <0.001 | — | — | — | — |
Lewy bodies | |||||||
No | 1.0 | 1.0 | — | 1.0 | — | — | — |
Yes | 3.2 | 1.5–6.9 | <0.003 | 3.5 | 1.3–9.3 | 3 | 1–7 |
Vascular disease (VD) | — | — | — | Not included | — | Not included | — |
None | 1.0 | — | — | — | — | — | — |
One of infarct/lacune/haemorrhage | 0.7 | 0.3–1.9 | — | — | — | — | — |
SVD only | 1.6 | 0.9–2.8 | — | — | — | — | — |
Multiple | 2.5 | 1.4–4.3 | <0.004 | — | — | — | — |
Overall vascular pathology | |||||||
None | 1.0 | — | — | 1.0 | — | — | — |
Infarcts/haemorrhage | 1.0 | 0.3–3.8 | — | 2.4 | 0.4–12 | — | — |
SVD/WML/lacunes | 2.5 | 1.4–4.4 | — | 3.7 | 1.5–9.6 | 12 | 3–19 |
Both | 2.9 | 1.6–5.5 | <0.003 | 4.8 | 1.9–12 | 9 | 3–15 |
Periventricular WML | — | — | — | Not included | — | Not included | — |
None | 1.0 | — | — | — | — | — | — |
Mild | 2.0 | 0.9–4.5 | — | — | — | — | — |
Moderate/severe | 4.3 | 1.9–9.8 | <0.001 | — | — | — | — |
Deep subcortical WML | — | — | — | Not included | — | Not included | — |
None | 1.0 | — | — | — | — | — | — |
Mild | 1.6 | 1.0–2.6 | — | — | — | — | — |
Moderate | 1.6 | 0.9–3.1 | — | — | — | — | — |
Severe | 3.3 | 1.6–6.8 | <0.01 | — | — | — | — |
Hippocampal atrophy | |||||||
None | 1.0 | 1.0 | — | 1.0 | 1.0 | — | — |
Mild | 2.2 | 1.3–3.9 | — | 1.8 | 0.9–3.7 | 2 | 0–6 |
Moderate | 6.9 | 3.7–13 | — | 3.4 | 1.5–7.5 | 8 | 2–15 |
Severe | 11.1 | 2.5–50 | <0.001 | 3.4 | 1.5–7.5 | 8 | 2–15 |
Neocortical atrophy | — | — | — | Not included | — | Not included | — |
None | 1.0 | 1.0 | — | — | — | — | — |
Mild | 1.6 | 1.0–2.8 | — | — | — | — | — |
Moderate | 5.9 | 3.3–10 | — | — | — | — | — |
Severe | 37.8 | 5.0–29 | <0.01 | — | — | — | — |